Number of Nucleoli and Nucleolar Organizer Regions per Nucleus and Nucleolus — Prognostic Value in Canine Mammary Tumors

Twenty-eight canine mammary tumors were evaluated for histopathologic classification as recommended by the World Health Organization and silver-binding nucleolar organizer region (AgNOR) and nucleolus counts. Samples of surgically excised tumors and tumors taken at necropsy were fixed in neutral formalin, embedded in paraffin, and cut into 1-3-μm-thick sections. Two sections were taken from each tumor: one was stained with hematoxylin and eosin and the other was treated with the silver staining technique for the demonstration of AgNORs. After histopathologic classification, the number of nucleoli and the number of AgNORs/nucleus and AgNORs/nucleolus were determined. Statistical analysis (Student's t-test) showed a significant difference in the mean number of nucleoli (P < 0.005), mean number of AgNORs/nucleolus (P < 0.001), and mean number of AgNORs/nucleus (P < 0.005) between benign and malignant canine mammary tumors. There was no significant differences between metastatic and nonmetastatic malignant tumors.

[1]  S. Olin,et al.  Mammary gland neoplasia. , 1996, Environmental health perspectives.

[2]  D. Ploton.  Structure and molecular organization of the nucleolus. , 1994, Zentralblatt fur Pathologie.

[3]  P. Hufnagl,et al.  Measuring of AgNORs using image analysis. , 1994, Zentralblatt fur Pathologie.

[4]  H. Martin.  [Importance of AgNOR analysis in malignant tumors]. , 1994, Zentralblatt fur Pathologie.

[5]  A. Mischlinski,et al.  Nucleolar organizer regions in human breast cancer. , 1993, Zentralblatt fur Pathologie.

[6]  J. Crocker,et al.  Correlation between Histologic Diagnosis Mean Nucleolar Organizer Region Count and Prognosis in Canine Mammary Tumors , 1992, Veterinary pathology.

[7]  S. Hinchliffe,et al.  Ploidy independence of Ag-NOR number in neuroblastoma. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[8]  M. von Lüdinghausen,et al.  Argyrophilic staining for nucleolar organizer region (AgNOR). A suitable methodology for differential diagnosis of breast lesions? , 1992, Zentralblatt fur Pathologie.

[9]  K. Kunze,et al.  The impact of nucleolar organizer regions for the lymph node spread and prognosis of invasive ductal mammary carcinoma. , 1991, Pathology, research and practice.

[10]  J. Crocker.  The nucleolar organizer regions , 1990 .

[11]  J. Crocker.  Nucleolar organiser regions. , 1990, Current topics in pathology. Ergebnisse der Pathologie.

[12]  K. Plate,et al.  Nucleolar organizer regions (NORs). Basic concepts and practical application in tumor pathology. , 1989, Pathology, research and practice.

[13]  Takuji Tanaka,et al.  Nucleolar Organizer Regions in Hepatocarcinogenesis Induced by N‐2‐Fluorenylacetamide in Rats: Comparison with Bromodeoxyuridine Immunohistochemistry , 1989, Japanese journal of cancer research : Gann.

[14]  A. Leong,et al.  Nucleolar organizer regions relate to growth fractions in human breast carcinoma. , 1989, Human pathology.

[15]  J. Lawry,et al.  Silver‐binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: Correlations with ploidy and growth phase by DNA flow cytometry , 1989, The Journal of pathology.

[16]  M. Derenzini,et al.  Interphasic nucleolar organizer region distribution as a diagnostic parameter to differentiate benign from malignant epithelial tumors of human intestine , 1987, Virchows Archiv. B, Cell pathology including molecular pathology.

[17]  M. Derenzini,et al.  DISTRIBUTION OF INTERPHASE NUCLEOLAR ORGANISER REGIONS AND DIAGNOSIS OF MALIGNANCY , 1987, The Lancet.

[18]  J. Crocker,et al.  Nucleolar organizer regions in lymphomas , 1987, The Journal of pathology.

[19]  D. Bostock.  Canine and feline mammary neoplasms. , 1986, The British veterinary journal.

[20]  S. Gilbertson,et al.  Prognostic factors in canine mammary tumors. , 1986, Seminars in veterinary medicine and surgery.

[21]  W. Priester.  Occurrence of mammary neoplasms in bitches in relation to breed, age, tumour type, and geographical region from which reported. , 1979, The Journal of small animal practice.

[22]  D. Macvean,et al.  Classification of Epithelial Canine Mammary Tumors in a Defined Population , 1977, Veterinary pathology.

[23]  E. H. Fowler,et al.  Biologic Behavior of Canine Mammary Neoplasms Based on a Histogenetic Classification , 1974, Veterinary pathology.

[24]  J. Hampe,et al.  Tumours and dysplasias of the mammary gland. , 1974, Bulletin of the World Health Organization.

[25]  J. Hampe,et al.  Canine Malignant Mammary Tumors , 1973 .

[26]  J. Hampe,et al.  Canine Malignant Mammary Tumours II. Adenocarcinomas, Solid Carcinomas and Spindle Cell Carcinomas , 1972, Veterinary pathology.

[27]  A. G. Jabara,et al.  The Effects of Progesterone and Ovariectomy on Mammary Tumours Induced by 7,12‐Dimethylbenz(A) Anthracene in Sprague‐Dawley Rats , 1970, Pathology.

[28]  I. Fidler,et al.  The biological behavior of canine mammary neoplasms. , 1967, Journal of the American Veterinary Medical Association.

[29]  E. Cotchin.  Mammary neoplasms of the bitch. , 1958, Journal of comparative pathology.